Professor25 / iStockphoto.com
The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review (IPR) proceedings has sparked questions over state protections at the Patent Trial and Appeal Board (PTAB).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Patent Trial and Appeal Board, Allergan, Restasis, inter partes review, Saint Regis Mohawk Tribe, immunity, tribal immunity, MBHB, Unified Patents